Ristocetin: lyophilized, contains Tris and stabilizing agents. Can be used Ristocetin-induced platelet aggregation (RIPA) tests to detect von Willebrand disease, more specifically to highlight an increase affinity in von Willebrand factor (vWF) for GPIb in type 2B and to identify Bernard-Soulier syndrome. Ristocetin reagent can also be used with lyophilized platelets (AG006A) for the Ristocetin cofactor activity assay (vWF:RCo), to assist in the diagnosis of von Willebrand disease. For in vitro diagnostic use.
Related Products
| Reference | Product name | Packaging | Manufacturer |
|---|---|---|---|
| AG001K | ADP | 3 x 0.5ml (43µg) | HYPHEN Biomed |
| AG003K | Arachidonic acid | 3x 0.5ml (2.5mg) | HYPHEN Biomed |
| AG005K | Collagen | 3 x 0.5ml (0.5mg) | HYPHEN Biomed |
| AG002K | Epinephrine | 3 x 0.5ml (160µg) | HYPHEN Biomed |
| AG004K | Ristocetin | 3 x 0.5ml (7.5mg) | HYPHEN Biomed |
| AG006A | Lyophilised Platelets - small | 1 x 5 ml | HYPHEN Biomed |
| AG006K | Lyophilised Platelets - large | 3 x 5 ml | HYPHEN Biomed |
| 5D-67111 | Convulxin | 50 µg | 5-Diagnostics |